Provepharm Inc. is conducting a voluntary nationwide recall of Phenylephrine Hydrochloride Injection, USP, 10 mg/mL (Pharmacy ...
Although low-molecular-weight heparin (LMWH) has been recommended to prevent venous thromboembolism, its anticoagulant and anti-inflammatory effects in sepsis remain controversial. Owing to the ...
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
The recalled product, packaged in single dose 10ml vials, can be identified from its lot code, '24020027,' and expiry date, December 2025. It also has the national drug code (NDC) '81284-213-01.' ...
The Food and Drug Administration announced a recall last week of an injectable blood pressure drug used nationwide for treatment following anesthesia. The recall of the drug -- known as ...
Approximately one in three (35%) respondents reported that their facility had experienced a near miss during the past year due to a drug shortage. About one in four reported actual errors and one ...
Blood was obtained without tourniquet by cubital venous puncture with a 19 G cannula and immediately anticoagulated with 1 U/mL heparin (ratiopharm, Ulm, Germany). The blood of two ABO-compatible ...
In other cases, alternative drugs or dosage forms/strengths are available when a drug shortage occurs, although the purchase price is often high. But even when alternatives can be identified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback